Upcoming Workshops
- Part II of New Trends in ImmunotherapyRegister
Past Workshops
- Updates in the Treatment of Estrogen Receptor (ER), Progesterone Receptor (PR) and HER2 Positive Breast Cancer from the 45th Annual San Antonio Breast Cancer SymposiumPart II of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
- Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
- Living with Breast Cancer – Updates from the 45th San Antonio Breast Cancer Symposium (SABCS)Part I of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
- What’s New In Precision Medicine
- For Caregivers: Coping with Your Loved One’s Metastatic Triple Negative Breast CancerPart II of Living with Metastatic Triple Negative Breast Cancer
- Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
- Metastatic Breast Cancer: Treatment Updates
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
- The Role of Radiation Therapy in the Treatment of Breast Cancer
- Metastatic Breast Cancer in African Americans: New Treatments
- Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
- Updates from the 44th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
- The Latest Developments Reported at the 44th Annual San Antonio Breast Cancer Symposium (SABCS)Part I of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
- Metastatic Triple Negative Breast Cancer: For Caregivers, Coping with Your Loved One’s CancerPart II of Living with Triple Negative Breast Cancer
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- HER2-Positive Metastatic Breast Cancer: New Therapies
- Metastatic Breast Cancer: Treatment Updates
- Metastatic Triple Negative Breast Cancer: Strategies to CopePart I of Living with Triple Negative Breast Cancer
- Triple Negative Breast Cancer: Coping with the Fear of Recurrence
- Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart I of Equity. Every Patient. Every Day. Everywhere.
- Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
- The Latest Developments Reported from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)Part I of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
- Updates from the San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
- Caregiving for Your Loved One Living with Metastatic Triple Negative Breast CancerPart II of Life with Metastatic Triple Negative Breast Cancer
- Coping with Metastatic Triple Negative Breast CancerPart I of Life with Metastatic Triple Negative Breast Cancer
- Living with Metastatic Breast Cancer
- Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment
- Triple Negative Breast Cancer and African American Women
- What’s New in the Treatment of Breast Cancer for Women of All Ages
- What’s New in the Treatment of Metastatic Breast Cancer
- Breast Cancer and Older Women